Grantham, Mayo, Van Otterloo & Co. LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Grantham, Mayo, Van Otterloo & Co. LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2020$3,090,000
-4.2%
980,800
-11.5%
0.02%
-8.3%
Q2 2020$3,224,000
+15.0%
1,107,900
+11.4%
0.02%
+4.3%
Q1 2020$2,804,000
-23.7%
994,300
-12.2%
0.02%
-8.0%
Q4 2019$3,673,000
+27.9%
1,132,000
-14.9%
0.02%
+25.0%
Q3 2019$2,872,000
-45.5%
1,329,600
-20.8%
0.02%
-45.9%
Q2 2019$5,272,000
-15.8%
1,678,900
-0.3%
0.04%
-17.8%
Q1 2019$6,264,000
+4220.0%
1,683,800
+2531.1%
0.04%
+4400.0%
Q1 2017$145,000
-93.6%
63,997
-94.0%
0.00%
-91.7%
Q4 2016$2,269,000
-70.5%
1,070,509
-53.4%
0.01%
-66.7%
Q3 2016$7,689,000
-14.2%
2,295,234
-19.6%
0.04%
-2.7%
Q2 2016$8,959,000
+9.5%
2,853,102
+16.1%
0.04%
+19.4%
Q1 2016$8,182,000
+1075.6%
2,457,115
+1149.2%
0.03%
+933.3%
Q4 2015$696,000
-30.5%
196,700
-1.2%
0.00%0.0%
Q3 2015$1,001,000
+178.8%
199,000
+367.8%
0.00%
+200.0%
Q4 2013$359,000
-5.3%
42,543
-10.6%
0.00%0.0%
Q3 2013$379,000
-13.9%
47,607
-16.4%
0.00%0.0%
Q2 2013$440,00056,9330.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Silver Point Capital L.P. 23,783,273$58,745,0006.82%
Park West Asset Management LLC 14,397,212$35,561,0000.74%
GABELLI & Co INVESTMENT ADVISERS, INC. 633,700$1,565,0000.24%
JBF Capital, Inc. 543,990$1,344,0000.22%
Context Capital Management, LLC 465,172$1,149,0000.16%
Bellecapital International Ltd. 108,025$267,0000.09%
FNY Investment Advisers, LLC 100,000$247,0000.07%
WINTON GROUP Ltd 291,360$720,0000.05%
Freedom Investment Management, Inc. 54,735$135,0000.02%
HANCOCK WHITNEY CORP 187,757$464,0000.02%
View complete list of PDL BIOPHARMA INC shareholders